Literature DB >> 11761169

Interaction of glucuronic acid and iduronic acid-rich glycosaminoglycans and their modified forms with hydroxyapatite.

Sarah G Rees1, WassellDianaT Hughes, Graham Embery.   

Abstract

Proteoglycans and their spatial arms, glycosaminoglycans (GAGs), are known to interact with hydroxyapatite (HAP) and have been implicated as important modulators of mineralisation. In the present study isotherm data (0.02 M sodium acetate, pH 6.8) revealed that the iduronic-rich GAGs heparan sulphate, heparin and dermatan sulphate showed greater binding onto HAP with higher adsorption maxima compared with the glucuronic acid-rich GAGs chondroitin-4-sulphate, chondroitin-6-sulphate and hyaluronan. Chemically desulphated chondroitin showed no adsorption onto HAP. With the exception of hyaluronan, the GAGs studied showed no desorbability in sodium acetate buffer only, whereas in di-sodium orthophosphate, desorption occurred much more readily. The data indicates that GAG chemistry and conformation in solution greatly influence the interaction of these molecules with HAP. The conformational flexibility of iduronic acid residues may be an important determinant in the strong binding of iduronic acid-rich GAGs to HAP, increasing the possibility of the appended anionic groups matching calcium sites on the HAP surface, compared with more rigid glucuronic acid residues. This work provides important information concerning interfacial adsorption phenomena between the organic-inorganic phases of mineralised systems.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11761169     DOI: 10.1016/s0142-9612(01)00130-2

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  9 in total

1.  Heparinization of a biomimetic bone matrix: integration of heparin during matrix synthesis versus adsorptive post surface modification.

Authors:  Ulla König; Anja Lode; Petra B Welzel; Yuichiro Ueda; Sven Knaack; Anja Henß; Anke Hauswald; Michael Gelinsky
Journal:  J Mater Sci Mater Med       Date:  2013-11-20       Impact factor: 3.896

2.  Characterization of chondroitin sulfate from deer tip antler and osteogenic properties.

Authors:  Peraphan Pothacharoen; Kanchanok Kodchakorn; Prachya Kongtawelert
Journal:  Glycoconj J       Date:  2011-09-06       Impact factor: 2.916

3.  Biocompatibility evaluation of a novel hydroxyapatite-polymer coating for medical implants (in vitro tests).

Authors:  Gabriela Negroiu; Roxana M Piticescu; Gabrielle C Chitanu; Ion N Mihailescu; Livia Zdrentu; Marimona Miroiu
Journal:  J Mater Sci Mater Med       Date:  2007-11-08       Impact factor: 3.896

4.  CD44 and beta3 integrin organize two functionally distinct actin-based domains in osteoclasts.

Authors:  Anne Chabadel; Inmaculada Bañon-Rodríguez; David Cluet; Brian B Rudkin; Bernhard Wehrle-Haller; Elisabeth Genot; Pierre Jurdic; Ines M Anton; Frédéric Saltel
Journal:  Mol Biol Cell       Date:  2007-09-26       Impact factor: 4.138

5.  Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells.

Authors:  Bodil Fadnes; Lars Uhlin-Hansen; Inger Lindin; Øystein Rekdal
Journal:  BMC Cancer       Date:  2011-03-31       Impact factor: 4.430

6.  Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone.

Authors:  William R Thompson; Shannon Modla; Brian J Grindel; Kirk J Czymmek; Catherine B Kirn-Safran; Liyun Wang; Randall L Duncan; Mary C Farach-Carson
Journal:  J Bone Miner Res       Date:  2011-03       Impact factor: 6.741

7.  The identification of proteoglycans and glycosaminoglycans in archaeological human bones and teeth.

Authors:  Yvette M Coulson-Thomas; Vivien J Coulson-Thomas; Andrew L Norton; Tarsis F Gesteira; Renan P Cavalheiro; Maria Cecília Z Meneghetti; João R Martins; Ronald A Dixon; Helena B Nader
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

8.  Circulating glucuronic acid predicts healthspan and longevity in humans and mice.

Authors:  Andrew Ho; Jonah Sinick; Tõnu Esko; Krista Fischer; Cristina Menni; Jonas Zierer; Maria Matey-Hernandez; Kristen Fortney; Eric K Morgen
Journal:  Aging (Albany NY)       Date:  2019-09-26       Impact factor: 5.682

9.  The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells.

Authors:  Bodil Fadnes; Oystein Rekdal; Lars Uhlin-Hansen
Journal:  BMC Cancer       Date:  2009-06-15       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.